Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Microban Products Company currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 2 distinct examiners, indicating that the company is interacting with multiple officials at the USPTO. The active files are spread across 2 distinct art units, which suggests a broader technical focus than a single unit would provide.
The busiest examiner for this portfolio is GREENE, IVAN A, who is responsible for 1 pending office action. This examiner handles a portion of the 2 pending office actions currently active for the company. Because the workload is split between 2 distinct examiners, the company must ensure consistency in its arguments across the different individuals reviewing its applications.
With 2 pending office actions in 2 distinct art units, the company must navigate the specific procedural norms of multiple units. While GREENE, IVAN A is the busiest examiner with 1 pending office action, the overall strategy must account for the perspectives of both examiners involved. This distribution within the Biotechnology & Pharmaceuticals sector requires a coordinated approach to manage different examiner styles.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GREENE, IVAN A | 1 | 18.7% | +6.4% |
| ILLING, CAITLIN NORINE | 1 | 48.9% | +37.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19435987 | RESIDUAL URINE NEUTRALIZING COMPOSITIONS AND COATINGS | GREENE, IVAN A | — |
| 18382689 | DURABLE OMNIPHOBIC AND/OR HYDROPHOBIC ANTIMICROBIAL COATING | ILLING, CAITLIN NORINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18382689 | DURABLE OMNIPHOBIC AND/OR HYDROPHOBIC ANTIMICROBIAL COATING | ILLING, CAITLIN NORINE | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| 1767 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19435987 | RESIDUAL URINE NEUTRALIZING COMPOSITIONS AND COATINGS | GREENE, IVAN A | 1619 | §103§112 | Final Rejection | — | Pending | Dec 30, 2025 |
| 18382689 | DURABLE OMNIPHOBIC AND/OR HYDROPHOBIC ANTIMICROBIAL COATING | ILLING, CAITLIN NORINE | 1767 | §103§112 | Non-Final OA | — | Pending | Oct 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial